Effects of tanshinone IIA on transforming growth factor β1-Smads signal pathway in renal interstitial fibroblasts of rats

Abstract

The effects of tanshinone IIA (TSN) on transforming growth factor β1 (TGFβ1) signal transduction in renal interstitial fibroblasts of rats were studied in order to investigate its mechanism in prevention of renal interstitial fibrosis. Rat renal fibroblasts of the line NRK/49F were cultured in vitro, stimulated with 5 ng/mL TGFβ1 and pretreated with 10⁻⁶, 10⁻⁵, 10⁻⁴ mol/L TSN respectively. The mRNA levels of fibronectin (FN) were examined by RT-PCR. The protein expression of FN and Smads was detected by Western blot. TGFβ1 induced the expression of FN mRNA and Smads in a time-dependent manner in a certain range. Compared with pre-stimulation, the FN mRNA and protein levels were increased by 1.1 times and 1.5 times respectively (P<0.01, P<0.01), and the protein expression of phosphorylated Smad2/3 (p-Smad2/3) increased by 7 times at the end of TGFβ1 stimulation (P<0.01). TSN pretreatment may down-regulate the FN and p-Smad2/3 expression in a dose-dependent manner. 10⁻⁶ mol/L TSN pretreatment had no effect on the FN and p-Smad2/3 expression (both P>0.05). After pretreatment with 10⁻⁵ and 10⁻⁴ mol/L TSN, the FN mRNA levels were decreased by 28.1% and 43.8% respectively (P<0.05, P<0.01), the FN protein levels were decreased by 40% and 44% respectively (P<0.05, P<0.05), and the p-Smad2/3 protein expression were decreased by 40% and 65% respectively (P<0.05, P<0.01). The inhibitory effect of TSN on renal interstitial fibrosis may be related to its blocking effect on TGFβ1-Smads signal pathway in renal interstitial fibroblasts.

Keywords

tanshinone IIA / fibroblast / transforming growth factor β1 / Smads

References

[1] CataniaJ. M., ChenG., ParrishA. R.. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol, 2007, 292(3): F905-F911

[2] IwanoM., NeilsonE. G.. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens, 2004, 13(3): 279-284

[3] GaedekeJ., PetersH., NobleN. A., et al.. Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol, 2001, 13(5): 153-160

[4] OkadaH., KalluriR.. Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis. Curr Mol Med, 2005, 5(5): 467-474

[5] LiJ., CampanaleN. V., LiangR. J., et al.. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy. Am J Pathol, 2006, 169(5): 1527-1540

[6] WuS. H., LuC., DongL., et al.. Lipoxin A4 induced renal interstitial fibroblast apoptosis by up-regulating Smad expression. Chin J Nephrol (Chinese), 2004, 20(5): 339-342

[7] LeaskA., AbrahamD. J.. TGF-beta signaling and the fibrotic response. FASEB J, 2004, 18(7): 816-827

[8] LiuY.. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int, 2006, 69(2): 213-217

[9] YangW. F., ChengH. C., XiaB. J.. Effect of Tanshinone IIA on HSC proliferation and ECM secretion. J Prac Med (Chinese), 2003, 19(11): 2126-2128

[10] HuaH. Y., GuoX. G., YangB., et al.. Effect of sodium Tanshinone IIA sulfonate on human HSC. Pharmacol Clin Chin Material Med (Chinese), 2007, 23(6): 12-14

[11] XieH., ZhenZ., GongL. Y.. Effect of Tanshinone IIA on left ventricular hypertrophy of rats with spontaneous hypertension and its mechanism. J Prac Med (Chinese), 2004, 20(3): 258-260

[12] TangX. Z., ZhenZ., TangY., et al.. Reversal effect of Tanshinone IIA on cardiac fibrosis of rats with spontaneous hypertension and its mechanism. J Huazhong Univ Sci Technol [Med Sci], 2002, 31(3): 292-294

[13] SunX. W., CaoL., YuG. H., et al.. Effect of sodium Tanshinone IIA sulfonate on proliferation and cyclin E expression in human renal interstitial fibroblasts in vitro. Acta Acad Med Mil Tertiae (Chinese), 2007, 29(7): 585-587

[14] TangJ. H., ZhanC. Y.. Inhibitive effect of Tanshinone IIA on renal interstitial fibrosis in rats. J Inter Intens Med (Chinese), 2008, 14(1): 16-18

[15] LiN. J., LiH.. Effect of TGF-β/Smad signal transduction in renal fibrosis. Int J Urol Nephrol (Chinese), 2007, 27(1): 88-91

[16] WangW., KokaV., LanH. Y.. Transforming growth factor-beta and Smad signaling in kidney diseases. Nephrology, 2005, 10(1): 48-56

[17] StahlP. J., FelsenD.. Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal trans-differentiation: implications for fibrosis in kidney disease. Am J Pathol, 2001, 159(4): 1187-1192

[18] VerrecchiaF., MauvielA.. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol, 2002, 118(2): 211-215

[19] MaoY., SchwarzbauerJ. E.. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol, 2005, 24(6): 389-399

[20] KiribayashiK., MasakiT., NaitoT., et al.. Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK. Kidney Int, 2005, 67(3): 1126-1135